Fundus Cameras Market By Product Type (Mydriatic Fundus Cameras, Non-Mydriatic Fundus Cameras, Hybrid Fundus Cameras), By Portability (Tabletop Fundus Cameras, Handheld Fundus Cameras), By End-User (Hospitals, Ophthalmic Clinics, Diagnostic Centers), and By Region; Global Insights & Forecast (2023 – 2030)

As per Intent Market Research, the Fundus Cameras Market was valued at USD 2.4 billion in 2024-e and will surpass USD 4.2 billion by 2030; growing at a CAGR of 9.8% during 2025 - 2030.

The fundus cameras market is experiencing steady growth due to the increasing prevalence of retinal disorders, rising awareness of early disease detection, and advancements in imaging technologies. Fundus cameras play a crucial role in diagnosing and monitoring conditions such as diabetic retinopathy, glaucoma, age-related macular degeneration (AMD), and other retinal diseases. The growing geriatric population, coupled with the rising incidence of diabetes and hypertension, has further fueled demand for these diagnostic devices in ophthalmology and optometry practices.

Technological advancements, including AI-powered image analysis, ultra-widefield imaging, and integration with electronic health records (EHR), are enhancing diagnostic capabilities and driving adoption across healthcare settings. Additionally, the shift towards portable and user-friendly fundus cameras is expanding accessibility, particularly in teleophthalmology applications. As governments and healthcare organizations emphasize early screening programs for eye diseases, the fundus cameras market is poised for significant growth.

Non-Mydriatic Fundus Cameras is the Largest Product Type Owing to Patient Convenience and Faster Diagnosis

Non-mydriatic fundus cameras dominate the market due to their ability to capture high-quality retinal images without the need for pupil dilation. Unlike traditional mydriatic fundus cameras, these devices offer a more patient-friendly experience by eliminating the discomfort and extended recovery time associated with dilating eye drops. Their quick and efficient imaging capabilities make them a preferred choice for routine eye screenings in hospitals, clinics, and optical retail chains.

The increasing adoption of non-mydriatic fundus cameras is also driven by advancements in image processing and AI-based diagnostic tools, which enhance accuracy and automate retinal disease detection. Furthermore, their integration into teleophthalmology platforms supports remote diagnostics, enabling early detection and timely intervention for patients in underserved regions. As healthcare providers prioritize efficiency and patient comfort, the demand for non-mydriatic fundus cameras is expected to grow further.

Handheld Fundus Cameras is the Fastest Growing Portability Segment Owing to Mobility and Teleophthalmology Adoption

Handheld fundus cameras are experiencing rapid growth due to their portability, ease of use, and increasing adoption in point-of-care and telemedicine applications. These compact devices enable ophthalmologists and general practitioners to conduct retinal screenings in various settings, including rural areas, emergency departments, and mobile healthcare units. The ability to perform quick, on-the-spot diagnostics makes handheld fundus cameras particularly valuable for early detection of diabetic retinopathy and other vision-threatening conditions.

Advancements in miniaturization, wireless connectivity, and AI-powered image interpretation have further fueled the adoption of handheld fundus cameras. Additionally, their affordability compared to traditional tabletop models has made them more accessible to smaller clinics and optometry practices. As the demand for mobile and cost-effective diagnostic solutions increases, handheld fundus cameras are expected to witness substantial market expansion.

Hospitals is the Largest End-User Owing to High Patient Influx and Advanced Diagnostic Facilities

Hospitals account for the largest share of the fundus cameras market due to their role as primary centers for diagnosing and treating retinal diseases. With access to specialized ophthalmic departments, hospitals are equipped with advanced imaging technologies and trained professionals who can accurately interpret retinal scans. The growing burden of eye diseases, particularly in aging populations, has increased the need for comprehensive ophthalmic screening programs in hospital settings.

Additionally, hospitals are integrating AI-driven fundus imaging solutions to enhance diagnostic efficiency and facilitate early disease detection. Many hospitals are also partnering with research institutions to develop and validate new imaging technologies for improved patient outcomes. As hospital-based ophthalmology services continue to expand, the demand for fundus cameras in this segment is expected to remain strong.

North America is the Largest Region Owing to High Prevalence of Retinal Diseases and Advanced Healthcare Infrastructure

North America leads the fundus cameras market due to a high prevalence of retinal disorders, a well-established healthcare infrastructure, and strong adoption of advanced ophthalmic imaging technologies. The region has a large diabetic population at risk of developing diabetic retinopathy, a major driver for fundus camera adoption in routine eye screenings. Additionally, government initiatives and reimbursement policies supporting early detection programs have boosted market growth.

The presence of key market players, ongoing technological advancements, and increasing investments in AI-powered diagnostic tools have further strengthened North America's market position. With the growing emphasis on teleophthalmology and remote screening programs, the demand for portable and AI-integrated fundus cameras is expected to rise, maintaining North America's leadership in the global market.

Leading Companies and Competitive Landscape

The fundus cameras market is highly competitive, with major players such as Topcon Corporation, Carl Zeiss Meditec, Nidek Co. Ltd., Canon Medical Systems, and Optovue leading the industry. These companies focus on continuous innovation, integrating AI and digital imaging solutions to enhance diagnostic accuracy. Strategic collaborations, product launches, and acquisitions play a vital role in gaining a competitive edge.

Emerging players are also introducing cost-effective and portable fundus cameras to cater to smaller healthcare facilities and telemedicine applications. The increasing adoption of AI-based automated retinal screening solutions is reshaping the competitive landscape, with companies investing in software-driven enhancements. As the market evolves, innovation in imaging technology and accessibility will be key factors driving competitive success.

List of Leading Companies:

• Carl Zeiss Meditec AG
• Topcon Corporation
• Nikon Corporation (NIDEK)
• Canon Inc.
• Kowa Company, Ltd.
• Optovue, Inc.
• CenterVue S.p.A.
• Heidelberg Engineering GmbH
• Volk Optical Inc.
• Optomed Oy (Ltd.)
• Ezer Digital Imaging
• Forus Health Pvt. Ltd.
• Remidio Innovative Solutions Pvt. Ltd.
• Clarity Medical Systems, Inc.
• Essilor Instruments USA

Recent Developments:

• In January 2025, Topcon Corporation launched an AI-powered fundus imaging system for enhanced diagnostic capabilities.
• In December 2024, Carl Zeiss Meditec introduced a next-generation hybrid fundus camera with integrated OCT technology.
• In November 2024, Nikon (NIDEK) expanded its portable fundus camera lineup to improve accessibility in remote areas.
• In October 2024, CenterVue S.p.A. collaborated with telemedicine providers to enhance remote retinal screening solutions.
• In September 2024, Canon Inc. received regulatory approval for its latest high-resolution fundus camera designed for early disease detection.

Report Scope: